Medigene appoints Dr. Thomas Taapken as Chief Financial Officer
November 22, 2016 01:30 ET
|
Medigene AG
Dr. Taapken contributes significant public company leadership experience, financing and strategic transaction expertise Martinsried/Munich, Germany, 22 November 2016. Medigene AG (MDG1, Frankfurt,...
Medigene highlights a new approach for neoantigen-specific TCRs at Neoantigen Summit 2016 in Boston
November 16, 2016 01:30 ET
|
Medigene AG
Proof-of-principle achieved using healthy donors for the generation of neoantigen-specific TCRs Proof-of- technology established using automated high-throughput processes Martinsried/Munich, 16...
Medigene stellt auf dem Neoantigen Summit 2016 in Boston neuen Ansatz für Neoantigen-spezifische TCRs vor
November 16, 2016 01:30 ET
|
Medigene AG
Machbarkeitsnachweis zur Generierung von Neoantigen-spezifischen TCRs mittels T-Zellen gesunder Spender erbracht Technische Erprobung zeigt Machbarkeit der automatisierten Hochdurchsatzprozesse ...
Medigene berichtet Ergebnisse für die ersten neun Monate 2016
November 10, 2016 01:30 ET
|
Medigene AG
Presse- und Analysten-Telefonkonferenz mit Webcast heute, 10. November 2016, um 15.00 Uhr MEZ Martinsried/München, 10. November 2016. Die Medigene AG (MDG1, Frankfurt, Prime Standard), ein...
Medigene reports its results for the first nine months of 2016
November 10, 2016 01:30 ET
|
Medigene AG
Telephone conference for analysts and the media via webcast today, November 10, 2016, 3 pm CET (Munich/Frankfurt) / 9:00 am EST (New York) Martinsried, Munich, November 10, 2016. Medigene AG...
Medigene nimmt an sechs nationalen und internationalen Konferenzen teil
November 04, 2016 02:31 ET
|
Medigene AG
Martinsried/München, 4. November 2016. Die Medigene AG (MDG1, Frankfurt, Prime Standard) gibt ihre Teilnahme an sechs bevorstehenden Wissenschafts-, Investoren- und Business Development Konferenzen...
Medigene participates at six national and international conferences
November 04, 2016 02:31 ET
|
Medigene AG
Martinsried/Munich, 4 November 2016. Medigene AG (MDG1, Frankfurt, Prime Standard) announces its participation at six upcoming scientific, investor and business development conferences: BioEurope ...
European Commission Grants Marketing Authorization for MediGene's Drug Oracea
July 29, 2008 02:41 ET
|
MediGene AG
MARTINSRIED/MUNICH, Germany, July 29, 2008 (PRIME NEWSWIRE) -- MediGene AG (Frankfurt:MDG) announced that the European Commission has acted on the recommendation by the European regulatory authority...
MediGene Exercises Option for Anti-L1 Monoclonal Antibody and Continues Collaboration With DKFZ (German Cancer Research Center)
July 17, 2008 02:44 ET
|
MediGene AG
MARTINSRIED/ MUNICH, Germany, July 17, 2008 (PRIME NEWSWIRE) -- MediGene AG (Frankfurt:MDG) announced that, according to plan, an option, granted two years ago by the German Cancer Research Center...